Tumors as elusive targets of T-cell-based active immunotherapy.
Explore this paper's citation graph
Summary
Current knowledge of the different 'levels' of immune response that might be necessary for immunotherapy to be effective in the treatment of cancer are reviewed and the mechanism(s) governing tumor rejection by the immune system in response to TA-specific immunization is discussed.
- Type
- review
- Published
- 2003-06-01
- Cited by
- 215
- References
- 67
- OpenAlex
- https://openalex.org/W2099613594
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:36766290
Keywords
Immune system, Immunotherapy, Tumor microenvironment, Immunology, Biology
References
- Array of hope
- Expansion of Tumor-T Cell Pairs from Fine Needle Aspirates of Melanoma Metastases
- Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides.
- Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
- Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance
- Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta‐thromboglobulin.
- Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.
- Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.
- Kinetics of TCR Use in Response to Repeated Epitope-Specific Immunization
- Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues.
- Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors.
- Skewed maturation of memory HIV-specific CD8 T lymphocytes
- Immune selection after antigen-specific immunotherapy of melanoma.
- Phase I Trial Of Intravenous Peptide-Pulsed Dendritic Cells in Patients With Metastatic Melanoma
- Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.
- Cancer as a complex adaptive system.
- Large clonal expansions of CD8+ T cells in acute infectious mononucleosis
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
- Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
- HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story.
Cited by
- A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer.
- A Novel HLA-A*0201 Restricted Peptide Derived From Cathepsin G Is An Effective Immunotherapeutic Target in Acute Myeloid Leukemia
- Cancer vaccines
- Analysis of Vaccine-Induced T Cells in Humans with Cancer
- Control of CD8 T-cell Infiltration into Tumors by Vasculature and Microenvironment
- Gene profiling for the prediction of tumor response to treatment: the case of immunotherapy.
- 免疫療法・遺伝子治療の問題点は何か, どう克服するか?
- A Novel Approach to Characterize Clonality and Differentiation of Human Melanoma-Specific T Cell Responses: Spontaneous Priming and Efficient Boosting by Vaccination1
- Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
- Developing cancer immunotherapies
- Melanoma-restricted genes
- Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines.
- Role of tumor architecture in elicitation of effector functions of human cytotoxic T-lymphocytes recognizing melanoma associated antigens
- Role of Antigen-Processing Machinery in the In Vitro Resistance of Squamous Cell Carcinoma of the Head and Neck Cells to Recognition by CTL1
- Obligate anaerobic Salmonella typhimurium strain YB1 treatment on xenograft tumor in immunocompetent mouse model.
- Intralesional Injection of Adenovirus Encoding CC Chemokine Ligand 16 Inhibits Mammary Tumor Growth and Prevents Metastatic-Induced Death after Surgical Removal of the Treated Primary Tumor1
- CTL Adoptive Immunotherapy Concurrently Mediates Tumor Regression and Tumor Escape
- Sperm protein 17 is expressed in human nervous system tumours
- Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection
- Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival.
Related papers
- Inhibition of immune responses to sheep red cells in rats pre-immunized with heterophilic antigen.
- Immunotherapy for Cancer: Harnessing the Power of the Immune System
- Immunotherapy: Reshape the Tumor Immune Microenvironment
- The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
- Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy.
- Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer
- Differential Role of PD-1 Expressed by Various Immune and Tumor Cells in the Tumor Immune Microenvironment: Expression, Function, Therapeutic Efficacy, and Resistance to Cancer Immunotherapy
- Non-immune cell components in tumor microenvironment influencing lung cancer Immunotherapy.
- A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors.
- Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer